Improvement of Patients with Long COVID 19
DOI:
https://doi.org/10.47363/JOLRR/2024(3)12Keywords:
COVID‐19, Pulmonary FibrosisAbstract
Introduction: The term “long-term Covid” is commonly used to describe signs and symptoms that persist or develop after acute Covid-19. Recovery time for these patients may vary depending on other comorbidities and the severity of the disease, severely ill patients are more likely to have a longer course than those with mild or moderate disease.
Objective: The purpose of the study is the management of patients with post-Covid-19 complications, with the aim of early treatment of these complications, so that patients can return to their previous lives.
Materials and Methods: This is an observational study. Data were collected from the medical records of 60 patients hospitalized in “Shefqet Ndroqi” hospital, Tirana, in the internal pathology ward, where post-Covid 19 patients are treated, were reviewed. Their demographic, clinical, physiological, laboratory and imaging data were collected. These patients were followed in the period, March 2022-June 2022.
Results: From the 60 patients who were clinically followed for 10 weeks, it was found that at the end of the 10th week, 25.6% of the patients had a significant improvement, 64% of the patients had a slight improvement, and 10.4% of these patients had no improvement. no improvement, compared to their previous condition.
Conclusion: The elderly and those with severe symptoms during the acute phase are at greater risk of moderate and severe sequelae, which require multidisciplinary management, according to the patient’s condition.